Literature DB >> 3427879

Alterations in aminoglycoside pharmacokinetics in patients with cancer.

G M Higa1, W E Murray.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3427879

Source DB:  PubMed          Journal:  Clin Pharm        ISSN： 0278-2677


× No keyword cloud information.
  9 in total

1.  Population pharmacokinetic study of amikacin administered once or twice daily to febrile, severely neutropenic adults.

Authors:  M Tod; O Lortholary; D Seytre; R Semaoun; B Uzzan; L Guillevin; P Casassus; O Petitjean
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

Review 2.  Antimicrobial treatment of febrile neutropenia: pharmacokinetic-pharmacodynamic considerations.

Authors:  Tiphaine Goulenok; Bruno Fantin
Journal:  Clin Pharmacokinet       Date:  2013-10       Impact factor: 6.447

3.  A Population Pharmacokinetic Model of Gentamicin in Pediatric Oncology Patients To Facilitate Personalized Dosing.

Authors:  C C Llanos-Paez; C E Staatz; R Lawson; S Hennig
Journal:  Antimicrob Agents Chemother       Date:  2017-07-25       Impact factor: 5.191

4.  Netilmicin pharmacokinetics in Hong Kong Chinese cancer patients.

Authors:  S Chang; R C Li; L S Chan; S Y Wong; M Zhu; A T Chan; K Raymond
Journal:  Br J Clin Pharmacol       Date:  1999-07       Impact factor: 4.335

5.  Increased aminoglycoside dosage requirements in hematologic malignancy.

Authors:  R G Zeitany; N S El Saghir; C R Santhosh-Kumar; M A Sigmon
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

Review 6.  Pharmacokinetics of anti-infective agents in paediatric patients.

Authors:  D R Butler; R J Kuhn; M H Chandler
Journal:  Clin Pharmacokinet       Date:  1994-05       Impact factor: 6.447

7.  Amikacin pharmacokinetics in patients receiving high-dose cancer chemotherapy.

Authors:  R L Davis; D Lehmann; C A Stidley; J Neidhart
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

8.  Aminoglycoside forecasting in neutropenic patients with cancer.

Authors:  J L Kosirog; R M Rospond; C Destache; P Hall
Journal:  Clin Pharmacokinet       Date:  1993-01       Impact factor: 6.447

9.  Population pharmacokinetics of gentamicin in patients with cancer.

Authors:  M C Rosario; A H Thomson; D I Jodrell; C A Sharp; H L Elliott
Journal:  Br J Clin Pharmacol       Date:  1998-09       Impact factor: 4.335
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.